MedPath

Early specialty palliative care for patients with advanced lung cancer undergoing chemotherapy: Feasbility study

Phase 1
Conditions
Advanced Lung Cancer
Registration Number
JPRN-UMIN000012772
Lead Sponsor
ational Cancer Center Hospital East
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

(1) recurrence after surgery for lung cancer. (2) with severe cognitive impairment. (3) already consulted outpatient palliative medicine clinic or outpatient psyco-oncology clinic before entry to this study. (4) already received intervention of specialty palliative care service before diagnosis. (5) participate in other intervention studies which prohibit participation in this study. (6) unable to read and respond to questions in Japanese. (7) judged to be inappropriate for participation to this study by the attending physician.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Completion rate of the questionnaires after second course of first-line chemotherapy
Secondary Outcome Measures
NameTimeMethod
(1) Functional Assessment of Cancer Therapy-Lung(FACT-L) (2) Patient Health Questionnaire 9(PHQ-9) (3) Hospital Anxiety and Depression Scale(HADS) (4) Rate of the patients received intervention of specialty palliative care service (5) Contents of intervention performed by specialty palliative care service
© Copyright 2025. All Rights Reserved by MedPath